Clinical Research Directory
Browse clinical research sites, groups, and studies.
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
Sponsor: M.D. Anderson Cancer Center
Summary
This study investigates the experiences of cancer patients with neuropathy during the COVID-19 pandemic to learn how the COVID-19 pandemic affects their quality of life and clinical outcomes. This study will also explore whether there are differences between patients who received neurofeedback (NFB, a type of therapy that is thought to help normalize brain activity) and those who did not. Learning about quality of life in cancer patients with neuropathy during the COVID-19 pandemic may help guide development of programs and policies to improve chronic pain patient care and outcomes during a major global healthcare crisis.
Official title: COVID-19: Well-Being in Cancer Patients With Neuropathy Who Participated in Prior Clinical Trials
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
274
Start Date
2020-05-26
Completion Date
2027-04-30
Last Updated
2025-10-14
Healthy Volunteers
No
Conditions
Interventions
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Complete questionnaire
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States